Posizioni attive di Rebecca Cohen
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| IKENA ONCOLOGY, INC. | Contatto Relazioni con gli Investitori | - | - |
Storia della carriera di Rebecca Cohen
Precedenti posizioni note di Rebecca Cohen
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SQZ BIOTECHNOLOGIES COMPANY | Contatto Relazioni con gli Investitori | 01/01/2017 | 01/07/2018 |
| Public Communications Contact | 01/01/2017 | 01/07/2018 | |
| EPIZYME, INC. | Public Communications Contact | - | 01/05/2016 |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
Posizioni
| Public Communications Contact | 2 |
| Investor Relations Contact | 2 |
Settori
| Health Technology | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| SQZ BIOTECHNOLOGIES COMPANY | Health Technology |
| IKENA ONCOLOGY, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Rebecca Cohen
- Esperienza
